Blab Tech
American Academy of Family Physicians Adapts to AI-Driven Health Misinformation
When a new generation of AI chatbots can spin any claim into a credible story, the American Academy of Family Physicians (AAFP) has had to rethink its playbook. In a briefing to Ragan Communications, the AAFP acknowledged that generative artificial intelligence does not create misinformation, but it does accelerate and complicate the correction process.
During the Ragan Crisis Communications Virtual Conference, Rebecca Fuller, vice president of integrated marketing communications at the AAFP, explained that the organization has long dealt with rumors. "We didn’t (use to) have digital platforms spreading (information) quite so quickly. We didn’t have technology and tools that made it look and sound quite as believable as it sounds today," Fuller said. She added that AI can take valid information, old news, and partial truths and combine them into something that sounds credible but is not fully accurate.
Founded in 1947 and headquartered in Leawood, Kansas, the AAFP represents more than 128,000 family‑medicine practitioners across the United States. Historically, the organization has issued position statements and educational materials to guide clinicians and patients. In recent years, the academy has faced a surge of misleading claims about vaccines, treatments, and disease prevention that appear on social media, search engines, and AI‑powered chatbots.
Experts point out that generative AI models can produce what is known as "hallucinations"—plausible‑sounding statements that contain false or incomplete information. A systematic review published in January 2026 highlighted how these models can generate convincing but incorrect health narratives at scale, emphasizing the need for transparent, explainable AI solutions to maintain public trust.
Facing this new threat, the AAFP has altered the source, framing, and placement of its messaging. Rather than simply publishing additional facts when a rumor gains traction, the organization now prioritizes who delivers the information, how it is contextualized, and where it appears online. This approach aims to reduce the influence of AI‑generated misinformation by ensuring that credible voices are front and center.
The shift reflects broader industry concerns. Health misinformation can lead to harmful behaviors, such as vaccine hesitancy or the use of unproven treatments. In 2025, the World Economic Forum identified misinformation as a top global risk, citing its potential to widen societal divides.
Regulatory frameworks are also evolving. The European Union’s Artificial Intelligence Act, which entered into force in August 2024, imposes transparency and quality obligations on high‑risk AI systems, including those used in healthcare. While the U.S. has yet to adopt a comprehensive AI regulation, several states have introduced guidelines for medical AI use.
The AAFP’s new strategy is still in its early stages. The organization has not announced any product launches or funding rounds related to this effort, and it remains to be seen how effective the revised messaging will be in countering AI‑driven misinformation.
In the meantime, the academy continues to monitor the misinformation landscape and adjust its communications accordingly. The broader challenge for health organizations is to develop robust, adaptable frameworks that can respond to the speed and scale of AI‑generated content while maintaining public trust.
The situation remains fluid, with ongoing research into AI hallucinations and evolving regulatory responses. The AAFP’s experience underscores the need for coordinated efforts among medical societies, technology developers, and policymakers to safeguard accurate health information in the digital age.
During the Ragan Crisis Communications Virtual Conference, Rebecca Fuller, vice president of integrated marketing communications at the AAFP, explained that the organization has long dealt with rumors. "We didn’t (use to) have digital platforms spreading (information) quite so quickly. We didn’t have technology and tools that made it look and sound quite as believable as it sounds today," Fuller said. She added that AI can take valid information, old news, and partial truths and combine them into something that sounds credible but is not fully accurate.
Founded in 1947 and headquartered in Leawood, Kansas, the AAFP represents more than 128,000 family‑medicine practitioners across the United States. Historically, the organization has issued position statements and educational materials to guide clinicians and patients. In recent years, the academy has faced a surge of misleading claims about vaccines, treatments, and disease prevention that appear on social media, search engines, and AI‑powered chatbots.
Experts point out that generative AI models can produce what is known as "hallucinations"—plausible‑sounding statements that contain false or incomplete information. A systematic review published in January 2026 highlighted how these models can generate convincing but incorrect health narratives at scale, emphasizing the need for transparent, explainable AI solutions to maintain public trust.
Facing this new threat, the AAFP has altered the source, framing, and placement of its messaging. Rather than simply publishing additional facts when a rumor gains traction, the organization now prioritizes who delivers the information, how it is contextualized, and where it appears online. This approach aims to reduce the influence of AI‑generated misinformation by ensuring that credible voices are front and center.
The shift reflects broader industry concerns. Health misinformation can lead to harmful behaviors, such as vaccine hesitancy or the use of unproven treatments. In 2025, the World Economic Forum identified misinformation as a top global risk, citing its potential to widen societal divides.
Regulatory frameworks are also evolving. The European Union’s Artificial Intelligence Act, which entered into force in August 2024, imposes transparency and quality obligations on high‑risk AI systems, including those used in healthcare. While the U.S. has yet to adopt a comprehensive AI regulation, several states have introduced guidelines for medical AI use.
The AAFP’s new strategy is still in its early stages. The organization has not announced any product launches or funding rounds related to this effort, and it remains to be seen how effective the revised messaging will be in countering AI‑driven misinformation.
In the meantime, the academy continues to monitor the misinformation landscape and adjust its communications accordingly. The broader challenge for health organizations is to develop robust, adaptable frameworks that can respond to the speed and scale of AI‑generated content while maintaining public trust.
The situation remains fluid, with ongoing research into AI hallucinations and evolving regulatory responses. The AAFP’s experience underscores the need for coordinated efforts among medical societies, technology developers, and policymakers to safeguard accurate health information in the digital age.
